Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Sells BeadStation To Galileo Genomics, Obtains Dx Rights

NEW YORK, Aug. 19 (GenomeWeb News) - Galileo Genomics has purchased two of Illumina's BeadStation 500GX genotyping systems for its disease gene discovery programs in an agreement that could be worth $1.5 million to Illumina, the companies said today.

 

Under the agreement, Galileo will use the genotyping systems in five disease gene association studies that use DNA samples from the Quebec Founder population, a pool of 6 million individuals of French descent in Quebec. Illumina will receive rights to diagnostics that could be developed from biomarkers discovered in the program, as well as from Galileo's existing gene discovery program for osteoarthritis.

 

The first disease that Galileo is studying under this program is the chronic gastrointestinal disorder Crohn's disease. The company has already conducted genome-wide scans of 1,500 individuals within the Quebec Founder population to identify candidate regions associated with the disease, and will now analyze SNPs within that region, the companies said.  The companies did not specify the four other diseases to be studied under the program.

 

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.